Endocrine, Metabolic and Immune Disorders - Drug Targets Impact factor 2025

---

The latest impact factor of Endocrine, Metabolic and Immune Disorders - Drug Targets and all the other Web of Science journals was released on 20th June 2025 by Clarivate. Through this web page, researchers can check the impact factor, total citation, journal quartile, and journal aim & scope.

Endocrine, Metabolic and Immune Disorders - Drug Targets: Aim & Scope

Endocrine, Metabolic and Immune Disorders - Drug Targets is a Web of Science indexed journal tha publishes research in the area: Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3).
The ISSN of this journal is 22123873.

Impact factor of Endocrine, Metabolic and Immune Disorders - Drug Targets

Journal Title	Endocrine, Metabolic and Immune Disorders - Drug Targets
Impact Factor
SJR	0.427
ISSN	22123873
Quartile	Q3

The Journal Impact Factor is defined as citations to the journal in the JCR year to items published in the previous two years, divided by the total number of scholarly items, also known as citable items, (these comprise articles and reviews) published in the journal in the previous two years.

Impact factor data has a strong influence on the scientific community, affecting decisions on where to publish, whom to promote or hire, the success of grant applications, and even salary bonuses.

Only journals listed in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) receive an Impact Factor.

Similiar journals to publish

---

Endocrine, Metabolic and Immune Disorders - Drug Targets

ISSN: 22123873
Journal Impact:
Journal Scope: Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS

ISSN: 2212-3873
Journal Impact: 2
Journal Scope: Endocrinology & Metabolism | Immunology | Pharmacology & Pharmacy

Reviews in Endocrine and Metabolic Disorders

ISSN: 15732606
Journal Impact:
Journal Scope: Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1)

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

ISSN: 1573-2606
Journal Impact: 6.9
Journal Scope: Endocrinology & Metabolism

CNS and Neurological Disorders - Drug Targets

ISSN: 19963181
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)

Cardiovascular and Hematological Disorders - Drug Targets

ISSN: 22124063
Journal Impact:
Journal Scope: Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)

Infectious Disorders - Drug Targets

ISSN: 22123989
Journal Impact:
Journal Scope: Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS

ISSN: 1996-3181
Journal Impact: 2.7
Journal Scope: Neurosciences | Pharmacology & Pharmacy

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

ISSN: 1178-7007
Journal Impact:
Journal Scope: Internal Medicine (Q2); Pharmacology (Q2)

Endocrine and Metabolic Science

ISSN: 26663961
Journal Impact:
Journal Scope: Endocrinology, Diabetes and Metabolism (Q3); Endocrinology (Q4)

About SCI

SCI is a multidisciplinary citation index. Science Citation Index covers 9,000+ journals across 177 scientific disciplines. SCI was established in 1900 to the current. SCI-indexed journals are indexed by SCI and SSCI. SCI is described as the world's leading journal.

All journals covered in this database are reviewed for sufficiently high quality each year.

How to publish in SCI journals?